Literature DB >> 16933149

Comparative effects of ischemic pre and postconditioning on ischemia-reperfusion injury in spontaneously hypertensive rats (SHR).

Juliana C Fantinelli1, Susana M Mosca.   

Abstract

Brief episodes of myocardial ischemia-reperfusion applied early in reperfusion may attenuate the reperfusion injury, strategy called ischemic postconditioning (IPO). Our objective was to examine the effects of IPO compared with ischemic preconditioning (IP) on postischemic myocardial dysfunction in spontaneously hypertensive rats (SHR). Isolated hearts from SHR and normotensive WKY rats were subjected to the following protocols: (1) Ischemic control (IC): global ischemia 20 min (GI20) and reperfusion 30 min (R). (2) IPO: three cycles of R30sec-IG30sec at the onset of R; (3) IP: a cycle of IG5-R10 previous to GI20, (4) IPO in the presence of chelerythrine, an inhibitor of protein kinase C (PKC). Systolic and diastolic function were assessed through developed pressure (LVDP) and end diastolic pressure (LVEDP), respectively. Lipid peroxidation was estimated by thiobarbituric reactive substance (TBARS) concentration. IPO significantly improved postischemic dysfunction. At the end of R, LVDP recovered to 87 +/- 7% in WKY and 94 +/- 7% in SHR vs. 55 +/- 11% and 58 +/- 12% in IC hearts. LVEDP reached values of 24 +/- 6 mmHg for WKY and 24 +/- 3 mmHg for SHR vs. 40 +/- 8 and 42 +/- 5 mmHg in IC hearts. Similar protection was achieved by IP. TBARS contents of SHR hearts were significantly diminished by IP and IPO. PKC inhibition aborted the protection of myocardial function and attenuated the diminution of lipid peroxidation conferred by IPO. These data show that IPO was as effective as IP in improving the postischemic dysfunction of hearts from SHR hearts, and that this cardioprotection appears to be associated with a diminution of ROS-induced damage involving the PKC activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16933149     DOI: 10.1007/s11010-006-9296-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  25 in total

Review 1.  Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure.

Authors:  Abdelkarim Sabri; Susan F Steinberg
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

2.  Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade.

Authors:  Sebastian Philipp; Xi-Ming Yang; Lin Cui; Amanda M Davis; James M Downey; Michael V Cohen
Journal:  Cardiovasc Res       Date:  2006-02-23       Impact factor: 10.787

Review 3.  Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.

Authors:  R A Kloner; R B Jennings
Journal:  Circulation       Date:  2001-12-11       Impact factor: 29.690

4.  Comparative cardioprotective effects of cromakalim and diltiazem in ischemic hypertrophied rat hearts.

Authors:  G J Grover; S Dzwonczyk; T M Monticello
Journal:  Am J Physiol       Date:  1996-01

5.  Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways.

Authors:  Xi-Ming Yang; J Bradley Proctor; Lin Cui; Thomas Krieg; James M Downey; Michael V Cohen
Journal:  J Am Coll Cardiol       Date:  2004-09-01       Impact factor: 24.094

6.  Ischemic preconditioning translocates PKC-delta and -epsilon, which mediate functional protection in isolated rat heart.

Authors:  S Kawamura; K Yoshida; T Miura; Y Mizukami; M Matsuzaki
Journal:  Am J Physiol       Date:  1998-12

Review 7.  Preconditioning the myocardium: from cellular physiology to clinical cardiology.

Authors:  Derek M Yellon; James M Downey
Journal:  Physiol Rev       Date:  2003-10       Impact factor: 37.312

8.  Differences in ischaemia tolerance between hypertrophied hearts of adult and aged spontaneously hypertensive rats.

Authors:  L H Snoeckx; G J van der Vusse; W A Coumans; P H Willemsen; R S Reneman
Journal:  Cardiovasc Res       Date:  1993-05       Impact factor: 10.787

Review 9.  New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  Cardiovasc Res       Date:  2004-02-15       Impact factor: 10.787

10.  Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats.

Authors:  A Vegh; S Komori; L Szekeres; J R Parratt
Journal:  Cardiovasc Res       Date:  1992-05       Impact factor: 10.787

View more
  10 in total

Review 1.  Connexin 43 in ischemic pre- and postconditioning.

Authors:  Rainer Schulz; Kerstin Boengler; Andreas Totzeck; Yukun Luo; David Garcia-Dorado; Gerd Heusch
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

Review 2.  Protection of the abnormal heart.

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

3.  Ischemic postconditioning: mechanisms, comorbidities, and clinical application.

Authors:  Bruno Buchholz; Martín Donato; Verónica D'Annunzio; Ricardo J Gelpi
Journal:  Mol Cell Biochem       Date:  2014-03-13       Impact factor: 3.396

Review 4.  Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

5.  Effects of Short-term Renovascular Hypertension and Type 2 Diabetes on Cardiac Functions in Rats.

Authors:  Ali Akbar Nekooeian; Azadeh Khalili; Mohammad Bagher Khosravi
Journal:  Iran J Med Sci       Date:  2014-01

Review 6.  Protein Kinases as Drug Development Targets for Heart Disease Therapy.

Authors:  Naranjan S Dhalla; Alison L Müller
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-05

7.  Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivo.

Authors:  Jianhui Li; Noureddine Loukili; Nathalie Rosenblatt-Velin; Pal Pacher; François Feihl; Bernard Waeber; Lucas Liaudet
Journal:  PLoS One       Date:  2013-07-10       Impact factor: 3.240

8.  Endogenous hydrogen sulfide mediates the cardioprotection induced by ischemic postconditioning in the early reperfusion phase.

Authors:  Yi-E Huang; Zhi-Han Tang; Wei Xie; Xin-Tian Shen; Mi-Hua Liu; Xiang-Ping Peng; Zhan-Zhi Zhao; DE-Bo Nie; Lu-Shan Liu; Zhi-Sheng Jiang
Journal:  Exp Ther Med       Date:  2012-10-01       Impact factor: 2.447

9.  Gsk-3β inhibitors mimic the cardioprotection mediated by ischemic pre- and postconditioning in hypertensive rats.

Authors:  Luisa F González Arbeláez; Ignacio A Pérez Núñez; Susana M Mosca
Journal:  Biomed Res Int       Date:  2013-10-30       Impact factor: 3.411

10.  Ischaemic post-conditioning in rats: Responder and non-responder differ in transcriptome of mitochondrial proteins.

Authors:  Rolf Schreckenberg; Johann Klein; Hanna Sarah Kutsche; Rainer Schulz; Kamilla Gömöri; Péter Bencsik; Bettina Benczik; Bence Ágg; Éva Sághy; Péter Ferdinandy; Klaus-Dieter Schlüter
Journal:  J Cell Mol Med       Date:  2020-04-16       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.